MICRORNA-34A: POTENT TUMOR SUPPRESSOR, CANCER STEM CELL INHIBITOR, AND POTENTIAL ANTICANCER THERAPEUTIC


Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors

Background: Pediatric gastroenteropancreatic neuroendocrine tumors are exceedingly rare, resulting in most pediatric treatment recommendations being based on data derived from adults.Trametinib is a HAIR TOUCH UP kinase inhibitor that targets MEK1/2 and has been employed in the treatment of cancers harboring mutations in the Ras pathway.Methods: We

read more

Laparoscopic Redo PyeloplastyAfter Failed OpenSurgery

PURPOSE: To report our experience in treating patients with failed previous open pyeloplasty by transperitoneal laparoscopic pyeloplasty.MATERIALS AND METHODS: Eleven patients with previous failed open pyeloplasty were reviewed, all of whom had undergone transperitoneallaparascopicpyeloplasty.All procedures were performed by a single team.Depending

read more